Adamis Pharmaceuticals PE Ratio 2006-2019 | ADMP

Current and historical p/e ratio for Adamis Pharmaceuticals (ADMP) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Adamis Pharmaceuticals PE ratio as of December 06, 2019 is 0.00.
Adamis Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-06 0.55 0.00
2019-09-30 0.70 $-0.63 0.00
2019-06-30 1.30 $-0.84 0.00
2019-03-31 2.11 $-0.97 0.00
2018-12-31 2.25 $-1.01 0.00
2018-09-30 3.50 $-0.97 0.00
2018-06-30 3.20 $-0.97 0.00
2018-03-31 3.50 $-0.87 0.00
2017-12-31 4.40 $-0.90 0.00
2017-09-30 5.23 $-0.66 0.00
2017-06-30 5.20 $-0.86 0.00
2017-03-31 4.25 $-1.04 0.00
2016-12-31 3.15 $-1.26 0.00
2016-09-30 3.43 $-1.47 0.00
2016-06-30 2.80 $-1.30 0.00
2016-03-31 6.13 $-1.20 0.00
2015-12-31 5.40 $-1.04 0.00
2015-09-30 3.87 $-0.83 0.00
2015-06-30 4.20 $-0.79 0.00
2015-03-31 3.94 $-0.79 0.00
2014-12-31 6.17 $-0.65 0.00
2014-09-30 4.68 $-1.47 0.00
2014-06-30 4.81 $-1.28 0.00
2014-03-31 6.36 $-1.18 0.00
2013-12-31 6.39 $-1.00 0.00
2013-09-30 6.38 $-0.18 0.00
2013-06-30 11.22 $-0.17 0.00
2013-03-31 11.22 0 0.00
2012-12-31 12.07 0 0.00
2012-09-30 10.03 $-0.17 0.00
2012-06-30 12.41 $-0.51 0.00
2012-03-31 3.91 $-0.85 0.00
2011-12-31 2.89 $-0.85 0.00
2011-09-30 3.57 $-3.06 0.00
2011-06-30 3.74 $-3.57 0.00
2011-03-31 3.16 $-3.91 0.00
2010-12-31 3.66 $-3.91 0.00
2010-09-30 3.74 $-2.04 0.00
2010-06-30 4.42 $-1.53 0.00
2010-03-31 3.57 $-1.19 0.00
2009-12-31 5.44 $-1.36 0.00
2009-09-30 4.59 $-1.02 0.00
2009-06-30 2.98 $-0.85 0.00
2009-03-31 11.82 $-0.68 0.00
2008-12-31 6.75 $-0.85 0.00
2008-09-30 6.75 $-1.02 0.00
2008-06-30 11.82 $-2.54 0.00
2008-03-31 8.44 $-5.75 0.00
2007-12-31 8.44 $-8.78 0.00
2007-09-30 10.13 $-8.44 0.00
2007-06-30 15.19 $-15.26 0.00
2007-03-31 16.88 $-18.68 0.00
2006-12-31 10.13 $-28.74 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.034B $0.015B
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.153B 9.98
Zoetis (ZTS) United States $57.975B 34.68
Astellas Pharma (ALPMY) Japan $32.884B 16.42
Eisai (ESALY) Japan $21.873B 42.18
Grifols, S.A (GRFS) Spain $15.793B 20.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $14.809B 20.21
Neurocrine Biosciences (NBIX) United States $10.757B 507.87
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.088B 18.41
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.455B 10.80
IPSEN SA ADR (IPSEY) France $7.796B 0.00
Catalent (CTLT) United States $7.615B 30.98
Arrowhead Pharmaceuticals (ARWR) United States $6.438B 97.49
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.698B 16.89
FibroGen (FGEN) United States $4.135B 121.51
United Therapeutics (UTHR) United States $4.020B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.774B 13.79
Nektar Therapeutics (NKTR) United States $3.598B 0.00
Sage Therapeutics (SAGE) United States $3.340B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
PTC Therapeutics (PTCT) United States $3.032B 0.00
Xencor (XNCR) United States $2.329B 70.79
Heron Therapeutics (HRTX) United States $2.318B 0.00
Portola Pharmaceuticals (PTLA) United States $2.273B 0.00
Zogenix (ZGNX) United States $2.074B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.957B 62.40
Pacira Pharmaceuticals (PCRX) United States $1.914B 56.63
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.816B 0.00
USANA Health Sciences (USNA) United States $1.652B 17.63
Corcept Therapeutics (CORT) United States $1.520B 18.47
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.456B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.264B 28.86
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.197B 0.00
ArQule (ARQL) United States $1.167B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.112B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.101B 7.51
Endo (ENDP) Ireland $1.098B 2.02
Karyopharm Therapeutics (KPTI) United States $1.023B 0.00
Radius Health (RDUS) United States $1.012B 0.00
Aerie Pharmaceuticals (AERI) United States $0.920B 0.00
Flexion Therapeutics (FLXN) United States $0.746B 0.00
Collegium Pharmaceutical (COLL) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.703B 0.00
TherapeuticsMD (TXMD) United States $0.659B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.493B 0.00
Organogenesis Holdings (ORGO) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.481B 58.38
Harpoon Therapeutics (HARP) United States $0.466B 0.00
Molecular Templates (MTEM) United States $0.452B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Ardelyx (ARDX) United States $0.430B 0.00
Dermira (DERM) United States $0.430B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 17.52
BioCryst Pharmaceuticals (BCRX) United States $0.396B 0.00
Indivior (INVVY) United States $0.385B 1.39
DURECT (DRRX) United States $0.377B 0.00
Recro Pharma (REPH) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Siga Technologies (SIGA) United States $0.359B 8.20
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.355B 4.13
OptiNose (OPTN) United States $0.352B 0.00
Concordia (CXRXF) Canada $0.333B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.332B 0.00
Rafael Holdings (RFL) United States $0.318B 0.00
GlycoMimetics (GLYC) United States $0.260B 0.00
Jounce Therapeutics (JNCE) United States $0.259B 3.46
KalVista Pharmaceuticals (KALV) United States $0.256B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
Xeris Pharmaceuticals (XERS) United States $0.236B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.236B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Aquestive Therapeutics (AQST) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.57
Foamix Pharmaceuticals (FOMX) Israel $0.187B 0.00
Concert Pharmaceuticals (CNCE) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.149B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.144B 0.00
IMV INC (IMV) Canada $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.137B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.089B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
PolarityTE (PTE) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.069B 0.00
Cardiome Pharma (CORV) Canada $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.73
CTI BioPharma (CTIC) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.023B 0.00
Shineco (TYHT) China $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00